Last updated on May 2018

A Study to Assess the Efficacy and Safety of H.P. Acthar Gel in Subjects With Active Systemic Lupus Erythematosus (SLE)


Brief description of study

Subjects with active systemic lupus erythematosus (SLE) will be randomized to receive Acthar or placebo. Active treatment will continue for 24 weeks. Efficacy will be assessed at multiple timepoints using the SLE Responder Index (SRI), SLEDAI-2K, BILAG, PGA, CLASI and 28 Joint Count

Detailed Study Description

This is a randomized, placebo controlled, double blind study. Following a screening period of up to 28 days, subjects with active systemic lupus erythematosus (SLE) including moderate to severe rash and/or arthritis despite corticosteroid therapy will be randomized in a 1:1 ratio to receive 1 mL (80 Units [U]) of Acthar or matching placebo. During Weeks 1 to 4, 1 mL (80 U) of Acthar or volume matched placebo will be administered subcutaneously (SC) every other day. For the remainder of the study (Weeks 5 to 24), Acthar 1 mL (80 U) or volume matched placebo will be administered SC 2x/week.

Clinical Study Identifier: NCT02953821

Find a site near you

Start Over

Advanced Pharma - Miami

2950 NW 83rd St Miami, FL USA
  Connect »

Precision Research Organization

Miami Lakes, FL United States
  Connect »

Millennium Research

Ormond Beach, FL United States
  Connect »

Omega Research Dalton

Dalton, GA United States
  Connect »

iResearch Atlanta

Decatur, GA United States
  Connect »

June DO, PC

Lansing, MI United States
  Connect »

Albuquerque Clinical Trials

Albuquerque, NM United States
  Connect »

DJL Clinical Research

Charlotte, NC United States
  Connect »

Paramount Medical Research & Consulting

Middleburg Heights, OH United States
  Connect »

ACME Research, LLC

Orangeburg, SC United States
  Connect »

Ramesh C. Gupta, MD

Memphis, TN United States
  Connect »

Sun Research Institute

San Antonio, TX United States
  Connect »

Primary Care Research

Atlanta, GA United States
  Connect »

Accurate Clinical Research

Houston, TX United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.